{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:58:34Z","timestamp":1761490714855},"reference-count":9,"publisher":"Impact Journals, LLC","issue":"96","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,12,7]]},"DOI":"10.18632\/oncotarget.26243","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T16:34:19Z","timestamp":1544200459000},"page":"36830-36832","source":"Crossref","is-referenced-by-count":4,"title":["Heparanase inhibitors restrain mesothelioma"],"prefix":"10.18632","volume":"9","author":[{"given":"Moshe","family":"Lapidot","sequence":"first","affiliation":[{"name":"Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri","family":"Barash","sequence":"additional","affiliation":[{"name":"Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Vlodavsky","sequence":"additional","affiliation":[{"name":"Cancer and Vascular Biology Research Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Pass","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Langone Medical Center, New York University School of Medicine, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Yang","year":"2012","journal-title":"J Cell Physiol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jnci\/djy032","article-title":"Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications","volume":"110","author":"Nagler","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"4","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1111\/j.1742-4658.2010.07799.x","article-title":"Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis","volume":"277","author":"Vlodavsky","year":"2010","journal-title":"FEBS J"},{"key":"5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12307-011-0082-7","article-title":"Significance of heparanase in cancer and inflammation","volume":"5","author":"Elkin","year":"2012","journal-title":"Cancer Microenviron"},{"key":"6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tibs.2017.10.007","article-title":"Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression","volume":"43","author":"Sanderson","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drup.2016.10.001","article-title":"Heparanase: from basic research to therapeutic applications in cancer and inflammation","volume":"29","author":"Ilan","year":"2016","journal-title":"Drug Resist Updat"},{"key":"8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1073\/pnas.1519453113","article-title":"Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis","volume":"113","author":"Ilan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI43792","article-title":"Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice","volume":"121","author":"Elkin","year":"2011","journal-title":"J Clin Invest"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T20:03:01Z","timestamp":1589054581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":9,"journal-issue":{"issue":"96","published-print":{"date-parts":[[2018,12,7]]}},"alternative-id":["26243","30627323"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26243","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]}}}